225 related articles for article (PubMed ID: 12088173)
1. Assessing cardiovascular risks versus clinical benefits of atypical antipsychotic drug treatment.
Meltzer HY; Davidson M; Glassman AH; Vieweg WV
J Clin Psychiatry; 2002; 63 Suppl 9():25-9. PubMed ID: 12088173
[TBL] [Abstract][Full Text] [Related]
2. Schizophrenia, antipsychotic drugs, and cardiovascular disease.
Glassman AH
J Clin Psychiatry; 2005; 66 Suppl 6():5-10. PubMed ID: 16107178
[TBL] [Abstract][Full Text] [Related]
3. Clinical management of cardiovascular risks during treatment with psychotropic drugs.
Glassman AH
J Clin Psychiatry; 2002; 63 Suppl 9():12-7. PubMed ID: 12088171
[TBL] [Abstract][Full Text] [Related]
4. Putting metabolic side effects into perspective: risks versus benefits of atypical antipsychotics.
Meltzer HY
J Clin Psychiatry; 2001; 62 Suppl 27():35-9; discussion 40-1. PubMed ID: 11806488
[TBL] [Abstract][Full Text] [Related]
5. [Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group].
Ames D; Camm J; Cook P; Falkai P; Gury C; Hurley R; Johnson G; Piepho R; Vieweg V;
Encephale; 2002; 28(6 Pt 1):552-62. PubMed ID: 12506268
[TBL] [Abstract][Full Text] [Related]
6. Risk of cardiovascular disease and sudden death in schizophrenia.
Davidson M
J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medications and cardiac conduction risks.
Roman M; Farmer SY
Issues Ment Health Nurs; 2010 Jan; 31(1):68-70. PubMed ID: 19951166
[No Abstract] [Full Text] [Related]
9. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
Kane JM; Leucht S; Carpenter D; Docherty JP;
J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
[TBL] [Abstract][Full Text] [Related]
10. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of antipsychotics.
Michelsen JW; Meyer JM
Expert Rev Neurother; 2007 Jul; 7(7):829-39. PubMed ID: 17610390
[TBL] [Abstract][Full Text] [Related]
12. Schizophrenia and comorbid metabolic disorders.
Henderson DC
J Clin Psychiatry; 2005; 66 Suppl 6():11-20. PubMed ID: 16107179
[TBL] [Abstract][Full Text] [Related]
13. Primary care issues in patients with mental illness.
Kiraly B; Gunning K; Leiser J
Am Fam Physician; 2008 Aug; 78(3):355-62. PubMed ID: 18711951
[TBL] [Abstract][Full Text] [Related]
14. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
Correll CU
J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
[TBL] [Abstract][Full Text] [Related]
15. Abstinence, anticipation, reduction, and treatment (AART): a stepwise approach to the management of atypical antipsychotic side effects.
Kennedy A; Tapp A; Kelly WS; Kilzieh N; Wood AE
Essent Psychopharmacol; 2006; 7(1):1-14. PubMed ID: 16989288
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risks of atypical antipsychotic drug treatment.
Drici MD; Priori S
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):882-90. PubMed ID: 17563919
[TBL] [Abstract][Full Text] [Related]
17. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of antipsychotics used in bipolar illness.
Piepho RW
J Clin Psychiatry; 2002; 63 Suppl 4():20-3. PubMed ID: 11913671
[TBL] [Abstract][Full Text] [Related]
19. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
Stahl SM; Mignon L; Meyer JM
Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
[TBL] [Abstract][Full Text] [Related]
20. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
